The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

C Sampson, Q Wang, W Otkur, H Zhao… - Clinical and …, 2023 - Wiley Online Library
Ubiquitination is one of the most important post‐translational modifications which plays a
significant role in conserving the homeostasis of cellular proteins. In the ubiquitination …

Current perspectives on taxanes: Focus on their bioactivity, delivery and combination therapy

J Škubník, V Pavlíčková, T Ruml, S Rimpelová - Plants, 2021 - mdpi.com
Taxanes, mainly paclitaxel and docetaxel, the microtubule stabilizers, have been well known
for being the first-line therapy for breast cancer for more than the last thirty years. Moreover …

Role of CD40 (L)-TRAF signaling in inflammation and resolution—a double-edged sword

L Strohm, H Ubbens, T Münzel, A Daiber… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular diseases (CVD) and cardiovascular risk factors are the leading cause of
death in the world today. According to the Global Burden of Disease Study, hypertension …

Targeting RNA helicase DDX3X with a small molecule inhibitor for breast cancer bone metastasis treatment

PT Winnard Jr, F Vesuna, GM Bol, KL Gabrielson… - Cancer Letters, 2024 - Elsevier
Patients who present with breast cancer bone metastasis only have limited palliative
treatment strategies and efficacious drug treatments are needed. In breast cancer patient …

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes

NG Kondegowda, J Filipowska, J Do… - Science …, 2023 - science.org
Treatment for type 1 diabetes (T1D) requires stimulation of functional β cell regeneration and
survival under stress. Previously, we showed that inhibition of the RANKL/RANK [receptor …

Tertiary motifs as building blocks for the design of protein‐binding peptides

S Swanson, V Sivaraman, G Grigoryan… - Protein …, 2022 - Wiley Online Library
Despite advances in protein engineering, the de novo design of small proteins or peptides
that bind to a desired target remains a difficult task. Most computational methods search for …

Novel methods of targeting IL-1 signalling for the treatment of breast cancer bone metastasis

J Zhou, JM Down, CN George, J Murphy, DV Lefley… - Cancers, 2022 - mdpi.com
Simple Summary The pro-inflammatory cytokine, IL1β, plays a pivotal role in breast cancer
bone metastasis. Inhibiting IL-1 signalling with the IL1β specific antibody, Canakinumab, or …

[HTML][HTML] Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic …

T Li, Z Lei, L Wei, K Yang, J Shen, L Hu - Journal of Cancer, 2024 - ncbi.nlm.nih.gov
Cancer imposes a substantial burden and its incidence is persistently increasing in recent
years. Cancer treatment has been difficult due to its inherently complex nature. The tumor …

The role of long non-coding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1) in chronic periodontitis progression

L Zhang, H Lv, Y Cui, R Shi - Bioengineered, 2022 - Taylor & Francis
Long non-coding RNA nuclear paraspeckle assembly transcript 1 (NEAT1) is a novel pro-
inflammatory factor in severe human diseases. Since inflammatory plays important roles in …

TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation

F Zeng, G Carrasco, B Li, A Sophocleous, AI Idris - Scientific Reports, 2023 - nature.com
TRAF6 has emerged as a key regulator of breast cancer (BCa). However, the TRAF family
constitutes of seven members that exhibit distinct and overlapping functions. To explore …